Institutional Ownership
Abbott Labs
CUSIP 002824100COMABTQ1 2026
Latest EPS (Diluted)
$0.61
Q1 2026 · Mar 31, 2026
Latest Revenue
$11.16B
Reported quarter
Latest Net Income
$1.08B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $0.62 | $0.61 | $11.16B | $1.08B | 10-Q |
| Sep 30, 2025 | Q3 2025 | $0.94 | $0.94 | $11.37B | $1.64B | 10-Q |
| Jun 30, 2025 | Q2 2025 | $1.02 | $1.01 | $11.14B | $1.78B | 10-Q |
| Mar 31, 2025 | Q1 2025 | $0.76 | $0.76 | $10.36B | $1.32B | 10-Q |
| Sep 30, 2024 | Q3 2024 | $0.94 | $0.94 | $10.63B | $1.65B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $0.74 | $0.74 | $10.38B | $1.30B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $0.70 | $0.70 | $9.96B | $1.23B | 10-Q |
| Sep 30, 2023 | Q3 2023 | $0.82 | $0.82 | $10.14B | $1.44B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $0.79 | $0.78 | $9.98B | $1.38B | 10-Q |
| Mar 31, 2023 | Q1 2023 | $0.75 | $0.75 | $9.75B | $1.32B | 10-Q |
| Sep 30, 2022 | Q3 2022 | $0.82 | $0.81 | $10.41B | $1.44B | 10-Q |
| Jun 30, 2022 | Q2 2022 | $1.15 | $1.14 | $11.26B | $2.02B | 10-Q |